These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 29253498

  • 1. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
    Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, Lu H, Guo J, Su Q, Shen H, Solon E, Comunale MA, Mehta A, Guo JT, Bavari S, Du Y, Block TM, Chang J.
    Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
    [Abstract] [Full Text] [Related]

  • 2. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.
    Chang J, Warren TK, Zhao X, Gill T, Guo F, Wang L, Comunale MA, Du Y, Alonzi DS, Yu W, Ye H, Liu F, Guo JT, Mehta A, Cuconati A, Butters TD, Bavari S, Xu X, Block TM.
    Antiviral Res; 2013 Jun; 98(3):432-40. PubMed ID: 23578725
    [Abstract] [Full Text] [Related]

  • 3. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J, Block TM, Guo JT.
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of a broad-spectrum antiviral with activity against Ebola virus.
    Aman MJ, Kinch MS, Warfield K, Warren T, Yunus A, Enterlein S, Stavale E, Wang P, Chang S, Tang Q, Porter K, Goldblatt M, Bavari S.
    Antiviral Res; 2009 Sep; 83(3):245-51. PubMed ID: 19523489
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
    Kolokoltsov AA, Adhikary S, Garver J, Johnson L, Davey RA, Vela EM.
    Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lack of protection against ebola virus from chloroquine in mice and hamsters.
    Falzarano D, Safronetz D, Prescott J, Marzi A, Feldmann F, Feldmann H.
    Emerg Infect Dis; 2015 Jun; 21(6):1065-7. PubMed ID: 25988934
    [Abstract] [Full Text] [Related]

  • 12. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T, Draper K, Brasel T, Freiberg A, Squiquera L, Sidransky D, Sulley J, Taxman DJ.
    Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.
    Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW, Smith EC, Poirier EZ, Simon-Loriere E, Prot M, Tamietti C, Vitry S, Volle R, Khou C, Frenkiel MP, Sakuntabhai A, Delpeyroux F, Pardigon N, Flamand M, Barba-Spaeth G, Lafon M, Denison MR, Albert ML, Vignuzzi M.
    J Virol; 2016 Nov 01; 90(21):9683-9692. PubMed ID: 27535047
    [Abstract] [Full Text] [Related]

  • 14. Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model.
    Smither SJ, Eastaugh LS, Steward JA, Nelson M, Lenk RP, Lever MS.
    Antiviral Res; 2014 Apr 01; 104():153-5. PubMed ID: 24462697
    [Abstract] [Full Text] [Related]

  • 15. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Madelain V, Duthey A, Mentré F, Jacquot F, Solas C, Lacarelle B, Vallvé A, Barron S, Barrot L, Mundweiler S, Thomas D, Carbonnelle C, Raoul H, de Lamballerie X, Guedj J.
    Antiviral Res; 2020 May 01; 177():104758. PubMed ID: 32135218
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.
    Warfield KL, Plummer EM, Sayce AC, Alonzi DS, Tang W, Tyrrell BE, Hill ML, Caputo AT, Killingbeck SS, Beatty PR, Harris E, Iwaki R, Kinami K, Ide D, Kiappes JL, Kato A, Buck MD, King K, Eddy W, Khaliq M, Sampath A, Treston AM, Dwek RA, Enterlein SG, Miller JL, Zitzmann N, Ramstedt U, Shresta S.
    Antiviral Res; 2016 May 01; 129():93-98. PubMed ID: 26946111
    [Abstract] [Full Text] [Related]

  • 17. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Westover JB, Sefing EJ, Bailey KW, Van Wettere AJ, Jung KH, Dagley A, Wandersee L, Downs B, Smee DF, Furuta Y, Bray M, Gowen BB.
    Antiviral Res; 2016 Feb 01; 126():62-8. PubMed ID: 26711718
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG, Julia BE, Vanessa MR, Victoria WJ, Thomas GW, Lisa HE.
    Infect Disord Drug Targets; 2009 Apr 01; 9(2):191-200. PubMed ID: 19275706
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.